Literature DB >> 18216357

Chimerism and tolerance in a recipient of a deceased-donor liver transplant.

Stephen I Alexander1, Neil Smith, Min Hu, Deborah Verran, Albert Shun, Stuart Dorney, Arabella Smith, Boyd Webster, Peter John Shaw, Ahti Lammi, Michael O Stormon.   

Abstract

Complete hematopoietic chimerism and tolerance of a liver allograft from a deceased male donor developed in a 9-year-old girl, with no evidence of graft-versus-host disease 17 months after transplantation. The tolerance was preceded by a period of severe hemolysis, reflecting partial chimerism that was refractory to standard therapies. The hemolysis resolved after the gradual withdrawal of all immunosuppressive therapy. Copyright 2008 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2008        PMID: 18216357     DOI: 10.1056/NEJMoa0707255

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  44 in total

Review 1.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Twisting immune responses for allogeneic stem cell therapy.

Authors:  Shengwen Calvin Li; Jiang F Zhong
Journal:  World J Stem Cells       Date:  2009-12-31       Impact factor: 5.326

3.  Immunosuppressive therapy and tolerance of organ allografts.

Authors:  Thomas E Starzl
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

4.  Novel diagnostics in renal transplantation.

Authors:  Niamh Kieran; Kim Muczynski; Vijayakrishna Vk Gadi
Journal:  Chimerism       Date:  2010-10

5.  Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination.

Authors:  T Okabayashi; A M Cameron; M Hisada; R A Montgomery; G M Williams; Z Sun
Journal:  Am J Transplant       Date:  2011-08-30       Impact factor: 8.086

Review 6.  Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Authors:  Michael Eikmans; Astrid G S van Halteren; Koen van Besien; Jon J van Rood; Jos J M Drabbels; Frans H J Claas
Journal:  Chimerism       Date:  2014

7.  The prospect of induced pluripotent stem cells for diabetes mellitus treatment.

Authors:  Andreas Soejitno; Pande Kadek Aditya Prayudi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-10       Impact factor: 3.565

8.  Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.

Authors:  Chunyan Zhang; Miao Wang; Jeremy J Racine; Hongjun Liu; Chia-Lei Lin; Indu Nair; Joyce Lau; Yu-An Cao; Ivan Todorov; Mark Atkinson; Defu Zeng
Journal:  Diabetes       Date:  2010-06-08       Impact factor: 9.461

9.  Stem cell transplantation for type 1 diabetes mellitus.

Authors:  Júlio C Voltarelli; Carlos Eduardo Barra Couri
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320

10.  Medication adherence among heart and/or lung transplant recipients: An exploratory study.

Authors:  Rebecca A O'Brien; Parisa Aslani; Maria A Ciccia; Jo-Anne E Brien
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.